Company News

Share this article:

Gilead Sciences Inc. has agreed to pay $1.4 billion, or $20 a share, for CV Therapeutics, a manufacturer of chest pain and heart drugs. The bid tops Astellas' $16-a-share bid for CV Therapeutics, announced last January.

 

GSW Worldwide's Pink Tank, an agency specializing in health marketing to women, has launched a new web site: www.knowher.com. The site provides information about strategic consulting services for clients who want to reach women consumers.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions